TENET HEALTHCARE ($THC) posted quarterly earnings results for Q1 2026 on Thursday, April 30th. The company reported earnings of $4.82 per share, beating estimates of $4.22 by $0.60. The company also reported revenue of $5,368,000,000, missing estimates of $5,450,557,263 by $-82,557,263.
You can see Quiver Quantitative's $THC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TENET HEALTHCARE Insider Trading Activity
TENET HEALTHCARE insiders have traded $THC stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- THOMAS W ARNST (EVP, Chief Admin. Officer & GC) has made 0 purchases and 3 sales selling 32,000 shares for an estimated $7,527,737.
- TAMMY ROMO has made 0 purchases and 6 sales selling 27,500 shares for an estimated $5,563,324.
- R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 6 sales selling 21,339 shares for an estimated $4,598,015.
- PAOLA M ARBOUR (EVP, Chief Information Officer) sold 6,500 shares for an estimated $1,549,795
- NADJA WEST sold 2,178 shares for an estimated $430,089
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
TENET HEALTHCARE Hedge Fund Activity
We have seen 321 institutional investors add shares of TENET HEALTHCARE stock to their portfolio, and 349 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LONE PINE CAPITAL LLC added 1,787,326 shares (+inf%) to their portfolio in Q4 2025, for an estimated $355,177,422
- WELLINGTON MANAGEMENT GROUP LLP added 1,042,260 shares (+1114.2%) to their portfolio in Q4 2025, for an estimated $207,117,907
- CITADEL ADVISORS LLC removed 1,020,474 shares (-96.7%) from their portfolio in Q4 2025, for an estimated $202,788,593
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 692,708 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $137,654,933
- PACER ADVISORS, INC. removed 538,299 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $106,970,777
- MILLENNIUM MANAGEMENT LLC removed 529,280 shares (-71.1%) from their portfolio in Q4 2025, for an estimated $105,178,521
- EMINENCE CAPITAL, LP removed 495,489 shares (-44.7%) from their portfolio in Q4 2025, for an estimated $98,463,574
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
TENET HEALTHCARE Government Contracts
We have seen $270,000 of award payments to $THC over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STERILE PROCESSING SERVICES: $135,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
TENET HEALTHCARE Congressional Stock Trading
Members of Congress have traded $THC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 1 purchase worth up to $50,000 on 12/10 and 1 sale worth up to $15,000 on 02/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
TENET HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $THC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- Barclays issued a "Overweight" rating on 11/21/2025
- JP Morgan issued a "Overweight" rating on 11/13/2025
To track analyst ratings and price targets for TENET HEALTHCARE, check out Quiver Quantitative's $THC forecast page.
TENET HEALTHCARE Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 12 analysts offer price targets for $THC in the last 6 months, with a median target of $264.5.
Here are some recent targets:
- Jason Cassorla from Guggenheim set a target price of $283.0 on 03/12/2026
- Ann Hynes from Mizuho set a target price of $265.0 on 03/12/2026
- Whit Mayo from Leerink Partners set a target price of $264.0 on 02/20/2026
- David Macdonald from Truist Securities set a target price of $270.0 on 02/17/2026
- Andrew Mok from Barclays set a target price of $257.0 on 02/13/2026
- Brian Tanquilut from Jefferies set a target price of $265.0 on 02/12/2026
- Ben Hendrix from RBC Capital set a target price of $277.0 on 02/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
